Attached files
file | filename |
---|---|
10-K - CASI Pharmaceuticals, Inc. | v178789_10k.htm |
EX-31.1 - CASI Pharmaceuticals, Inc. | v178789_ex31-1.htm |
EX-31.2 - CASI Pharmaceuticals, Inc. | v178789_ex31-2.htm |
EX-32.2 - CASI Pharmaceuticals, Inc. | v178789_ex32-2.htm |
EX-23.1 - CASI Pharmaceuticals, Inc. | v178789_ex23-1.htm |
Exhibit
32.1
CERTIFICATION
BY EXECUTIVE CHAIRMAN
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002
In
connection with the Annual Report of EntreMed, Inc. (the “Company”) on Form 10-K
for the period ended December 31, 2009 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Michael M. Tarnow, as Executive
Chairman of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best
of my knowledge, that:
|
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company
|
This
certificate is being made for the exclusive purpose of compliance by the
Executive Chairman of the Company with the requirements of Section 906 of the
Sarbanes-Oxley Act of 2002, and may not be used by any person or for any reason
other than as specifically required by law.
/s/ Michael M. Tarnow
|
|
March
29, 2010
|
Michael
M. Tarnow
Executive
Chairman
|